{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:56Z","timestamp":1760122256901},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.contraception.2013.04.003","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T18:16:45Z","timestamp":1366395405000},"page":"539-543","source":"Crossref","is-referenced-by-count":21,"title":["Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study"],"prefix":"10.1016","volume":"88","author":[{"given":"Angelo","family":"Cagnacci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Zanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serenella","family":"Arangino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annibale","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2013.04.003_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0010","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/bmj.39269.672188.AE","article-title":"Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study","volume":"335","author":"Conen","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2013.04.003_bb0015","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0020","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2013.04.003_bb0025","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2013.04.003_bb0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: ischaemic stroke and combined oral contraceptives: results of an international multicentre case control study","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(95)12394-6","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: haemorragic stroke, overall stroke risk, and combined oral contraceptives: results of an international multicentre case\u2013control study","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0040","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: acute myocardial infarction and combined oral contraceptives: results of an international multicentre case control study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0045","first-page":"1","article-title":"Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2013.04.003_bb0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.1.5907.533","article-title":"Blood pressure in women taking oral contraceptives","volume":"1","author":"Weir","year":"1974","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2013.04.003_bb0055","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1001\/jama.1977.03270500051024","article-title":"Oral contraceptives and blood pressure","volume":"237","author":"Fisch","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2013.04.003_bb0060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1471-0528.1984.tb04747.x","article-title":"A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen","volume":"91","author":"Wilson","year":"1984","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2013.04.003_bb0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0895-7061(95)96212-3","article-title":"Ambulatory blood pressure in mild hypertensive women taking oral contraceptives. A case\u2013control study","volume":"8","author":"Narkiewicz","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.contraception.2013.04.003_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/003693308202700303","article-title":"Effect on blood pressure of changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension","volume":"27","author":"Weir","year":"1982","journal-title":"Scott Med J"},{"key":"10.1016\/j.contraception.2013.04.003_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0010-7824(95)00097-T","article-title":"The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene","volume":"51","author":"Fuchs","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0010-7824(95)00153-2","article-title":"Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease","volume":"52","author":"Godsland","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0085","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Resting heart rate in cardiovascular disease","volume":"50","author":"Fox","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2013.04.003_bb0090","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2010.09.014","article-title":"Vascular pathophysiology in resonse to increased heart rate","volume":"56","author":"Custodis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.contraception.2013.04.003_bb0095","series-title":"Assessment of association of increased heart rates to cardiovascular events among healthy subjects in the United States: analysis of primary care electronic medical records database","author":"Asche","year":"2011"},{"key":"10.1016\/j.contraception.2013.04.003_bb0100","article-title":"Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study","author":"Cagnacci","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"Van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijgo.2011.03.008","article-title":"Combined contraceptive ring versus combined oral contraceptive (30-\u03bcg ethinylestradiol and 3-mg drospirenone)","volume":"114","author":"Mohamed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0115","first-page":"1462","article-title":"The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Guidelines for the management of arterial Hypertension","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.contraception.2013.04.003_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.maturitas.2003.08.011","article-title":"Administration of tibolone decreases 24-h heart rate but not blood pressure of post-menopausal women","volume":"48","author":"Cagnacci","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2013.04.003_bb0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/sim.2538","article-title":"Revisiting the relation between change and initial value: a review and evaluation","volume":"26","author":"Tu","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.contraception.2013.04.003_bb0130","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.fertnstert.2008.03.082","article-title":"Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome","volume":"91","author":"Luque-Ram\u00edrez","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2013.04.003_bb0135","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004872-199816030-00013","article-title":"A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women","volume":"16","author":"Straznicky","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.contraception.2013.04.003_bb0140","first-page":"19","article-title":"Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone","volume":"7","author":"Oelkers","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2013.04.003_bb0145","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2013.04.003_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-8703(84)90144-3","article-title":"Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey","volume":"107","author":"Goldhaber","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/j.contraception.2013.04.003_bb0155","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2013.04.003_bb0160","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","article-title":"Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2013.04.003_bb0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.contraception.2005.05.008","article-title":"Measured and reported weight change for women using a vaginal contraceptive ring vs a lowdose oral contraceptive","volume":"72","author":"O\u2019Connell","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0175","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2013.04.003_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 \u03bcg ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fertnstert.2005.06.040","article-title":"Comparison of uterine concentrations of ethinylestradiol and etonogestrel \u2013 after use of a contraceptive vaginal ring and an oral contraceptive","volume":"85","author":"Roumen","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2013.04.003_bb0190","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.fertnstert.2009.05.044","article-title":"Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study","volume":"94","author":"Battaglia","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2013.04.003_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/HJH.0b013e32835b8d8b","article-title":"Accuracy of ambulatory blood pressure monitors: a systematic review of validation studies","volume":"31","author":"Hodgkinson","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.contraception.2013.04.003_bb0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0020-7292(97)00239-7","article-title":"Low-dose oral contraceptives and 24-hour ambulatory blood pressure","volume":"59","author":"Cardoso","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2013.04.003_bb0205","article-title":"Blood pressure measurement prior to initiating hormonal contraception: a systematic review","author":"Tepper","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2013.04.003_bb0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/CS20120424","article-title":"Angiotensin II potentiates \u03b1-adrenergic vasoconstriction in the elderly","volume":"124","author":"Barrett-O'Keefe","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.contraception.2013.04.003_bb0215","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/00004872-199816120-00012","article-title":"Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension","volume":"16","author":"Grassi","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.contraception.2013.04.003_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/07853890108998748","article-title":"Heart rate as a cardiovascular risk factor: do women differ from men?","volume":"33","author":"Palatini","year":"2001","journal-title":"Ann Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782413001273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782413001273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T18:57:39Z","timestamp":1539716259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782413001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0010782413001273"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2013.04.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}